OptiNose is a Biotech company based in Yardley. It has raised $37M in total funding. Latest round: Series D.
OptiNose funding overview
OptiNose is a Biotech company based in Yardley. OptiNose has raised $37M in total disclosed funding. That places its disclosed total in the $25M–$100M range. Its most recent disclosed round is a Series D announced in May 2017. The round record for OptiNose runs through 2017; nothing later has been disclosed. Investors on record include Fidelity Management and Research Company, Avista Capital Partners, Entrepreneurs Fund. 3 distinct backers are named across the disclosed rounds.
OptiNose at a glance
Total raised
$37M
Latest round
Series D
Latest round date
May 2017
Industry
Biotech
Headquarters
Yardley
Notable investors
Fidelity Management and Research Company, Avista Capital Partners, Entrepreneurs Fund
Frequently asked about OptiNose funding
How much has OptiNose raised?
OptiNose has raised $37M in total disclosed funding across the rounds on record.
Who has invested in OptiNose?
Fidelity Management and Research Company, Avista Capital Partners, Entrepreneurs Fund are named among the investors backing OptiNose.
What was the latest OptiNose funding round?
The most recent disclosed round is a Series D, announced in May 2017.
Where is OptiNose based?
OptiNose is based in Yardley.
What sector does OptiNose operate in?
OptiNose is tracked under Biotech from Yardley, with $37M in disclosed funding.
When did OptiNose last raise?
The last disclosed OptiNose round closed in May 2017 at Series D.
OptiNose totals reflect disclosed capital only — undisclosed extensions and secondaries are excluded. Use the related Biotech companies in Yardley below to benchmark round size and investor mix.
